Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 6/2015

01-06-2015 | Stanford Multidisciplinary Seminars

More with Less: Pancreas-Preserving Total Duodenectomy

Authors: Motaz Qadan, Monica Dua, David Worhunsky, George Triadafilopoulos, Brendan Visser

Published in: Digestive Diseases and Sciences | Issue 6/2015

Login to get access

Excerpt

A 49-year-old man was initially referred to the hepatobiliary and pancreatic surgery team following an incidental discovery of a duodenal ampullary polyp during esophagogastroduodenoscopy (EGD), which was carried out for worsening gastroesophageal reflux disease (GERD) symptoms. …
Literature
1.
Cloyd JM, Kastenberg ZJ, Visser BC, Poultsides GA, Norton JA. Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy. J Gastrointest Surg. 2014;18:348–353.CrossRefPubMed
2.
Chung RS, Church JM, van Stolk R. Pancreas-sparing duodenectomy: indications, surgical technique, and results. Surgery. 1995;117:254–259.CrossRefPubMed
3.
Penninga L, Svendsen LB. Pancreas-preserving total duodenectomy: a 10-year experience. J Hepatobiliary Pancreat Sci.. 2011;18:717–723.CrossRefPubMed
4.
Gribble FM. The gut endocrine system as a coordinator of postprandial nutrient homoeostasis. Proc Nutr Soc. 2012;71:456–462.CrossRefPubMed
5.
6.
Sarmiento JM, Thompson GB, Nagorney DM, Donohue JH, Farnell MB. Pancreas-sparing duodenectomy for duodenal polyposis. Arch Surg. 2002;137:557–562.CrossRefPubMed
7.
Konishi M, Kinoshita T, Nakagohri T, Takahashi S, Gotohda N, Ryu M. Pancreas-sparing duodenectomy for duodenal neoplasms including malignancies. Hepatogastroenterology. 2007;54:753–757.PubMed
8.
Benetatos N, Ammori MB, Ammori BJ. Laparoscopic pancreas-preserving total duodenectomy for familial adenomatous polyposis. Surg Laparosc Endosc Percutan Tech. 2011;21:e332–e335.CrossRefPubMed
9.
Masrur M, Gheza F, Raimondi P, D’Ugo S, Calatayud D, Giulianotti PC. Robot-assisted subtotal pancreas-preserving duodenectomy. JSLS. 2012;16:654–659.CrossRefPubMedCentralPubMed
Metadata
Title
More with Less: Pancreas-Preserving Total Duodenectomy
Authors
Motaz Qadan
Monica Dua
David Worhunsky
George Triadafilopoulos
Brendan Visser
Publication date
01-06-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3331-z

Other articles of this Issue 6/2015

Digestive Diseases and Sciences 6/2015 Go to the issue

Original Article

Complete Resection of Colorectal Adenomas: What Are the Important Factors in Fellow Training?

Editorial

Optimizing the Interpretation of Capsule Endoscopic Images: Shortsighted or Taking the Long View?

Original Article

A Case Series and Literature Review of Merkel Cell Carcinoma Metastasizing to Pancreas

UNM Clinical Case Conferences

An Intimate Cause of Proctocolitis

Review

Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis

Original Article

Discrimination of Normal and Esophageal Cancer Plasma Proteomes by MALDI-TOF Mass Spectrometry
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits